Due to the fact Pirfenidone is metabolised with the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is probably going to precipitate the toxicity of pirfenidone: concomitant therapy would be to be prevented. Many of the people enrolled in one study on PFD and its effect on respiratory-associated hospitalization https://jamesb333sep7.wikiconverse.com/user